Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Thalassemia
Related studies linked through entity extraction aliases.
Stem Cell Transplant for Hemoglobinopathy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
- Status
- COMPLETED
- Phase
- PHASE2
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
- Status
- COMPLETED
- Phase
- PHASE2
Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
- Status
- TERMINATED
- Phase
- PHASE2
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
- Status
- TERMINATED
- Phase
- PHASE2
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
- Status
- TERMINATED
- Phase
- PHASE2
Combination Iron Chelation Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Deferoxamine for the Treatment of Hemochromatosis
- Status
- COMPLETED
- Phase
- N/A
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
- Status
- COMPLETED
- Phase
- PHASE2
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
- Status
- COMPLETED
- Phase
- PHASE2